2B ), anti-IL-1β mAb showed a trend towards improvement in the degree of ZIA pain (Supplemental Fig. 2C ), but not in disease development (Supplemental Fig. 2D ).
← all excerpts
The mode of action of IL-23 in experimental inflammatory arthritic pain and disease.
1
—
—